NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/11/2024
Voltar para busca
Dado oficial do USPTO
SYNTHIA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SYNTHIA
ST13
US500000087825579Classe
9, 38, 42, 45
Pedido
87825579
Registro
7575011
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
59
Atualização mais recente
26/11/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 38, 42, 45
Data de depósito
08/03/2018
Data de registro
26/11/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/11/2024
Última transação
26/11/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Darmstadt, DE
Examinador
HOWELL,MATTHEW PATTERSON
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Merck KGaA
Representantes
William C. Wright EPSTEIN DRANGEL LLP
Classificação técnica
Classes Nice
Classe 9Classe 38Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Electronic databases in the fields of drug development and drug manufacturingrecorded on computer media; bioinformatics software for storingindexingsearchingretrievingaccessing information about biological data for use in retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; chemoinformatics software for storingindexingsearchingretrievingaccessing information about chemical compounds and chemical data for use in retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; software for use in biological and chemical modellinganalysis and information management for use in retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; software for computer-aided molecular designdata processing and data analysis for use in retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; chemical data analysis software for use in retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; drug discovery information systems software used to solve problems in connection with chemical syntheses for use in the field of organic chemistry; none of the foregoing for use in connection with synthetic patientssimulated patientssynthetic electronic patient healthcare recordssynthetic patient data and associated healthcare recordsnor in the field of medical science and medical consultancy
Classe 38
Providing access to databases for use in retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; none of the foregoing for use in connection with synthetic patientssimulated patientssynthetic electronic patient healthcare recordssynthetic patient data and associated healthcare recordsnor in the field of medical science and medical consultancy
Classe 42
Biotechnology and pharmaceutical research relating to retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug development; professional consultancy in relation to drug development; scientific research and development for others; scientific research in the nature of analysis and preparation of data relating to retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discovery and drug development; provision of information in relation to drug discovery and drug development; provision of scientific information related to pharmacy; none of the foregoing for use in connection with synthetic patientssimulated patientssynthetic electronic patient healthcare recordssynthetic patient data and associated healthcare recordsnor in the field of medical science and medical consultancy
Classe 45
Licensing of computer software used for retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; none of the foregoing for use in connection with synthetic patientssimulated patientssynthetic electronic patient healthcare recordssynthetic patient data and associated healthcare recordsnor in the field of medical science and medical consultancy
Publicações
Histórico de despachos e eventos da marca no USPTO.
59 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
26/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/09/2024
PUBO
PUBLISHED FOR OPPOSITION
24/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
15/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/07/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
13/07/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
15/04/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
15/04/2024
CNSI
SUSPENSION INQUIRY WRITTEN
15/04/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/04/2024
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/10/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/10/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/03/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/03/2023
DOCK
ASSIGNED TO EXAMINER
14/02/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
30/11/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
28/04/2022
GNSL
LETTER OF SUSPENSION E-MAILED
28/04/2022
CNSL
SUSPENSION LETTER WRITTEN
28/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/02/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/02/2022
DOCK
ASSIGNED TO EXAMINER
03/11/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/08/2021
GNRT
NON-FINAL ACTION E-MAILED
23/08/2021
CNRT
NON-FINAL ACTION WRITTEN
23/08/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
26/06/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
23/06/2020
ALIE
ASSIGNED TO LIE
22/06/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
20/12/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/06/2019
GNSL
LETTER OF SUSPENSION E-MAILED
10/06/2019
CNSL
SUSPENSION LETTER WRITTEN
10/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/05/2019
ALIE
ASSIGNED TO LIE
16/05/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/05/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
19/03/2019
GNSL
LETTER OF SUSPENSION E-MAILED
19/03/2019
CNSL
SUSPENSION LETTER WRITTEN
19/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/03/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/11/2018
GNRT
NON-FINAL ACTION E-MAILED
08/11/2018
CNRT
NON-FINAL ACTION WRITTEN
08/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/10/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/04/2018
GNRT
NON-FINAL ACTION E-MAILED
04/04/2018
CNRT
NON-FINAL ACTION WRITTEN
04/04/2018
DOCK
ASSIGNED TO EXAMINER
27/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/03/2018
NWAP
NEW APPLICATION ENTERED
12/03/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SYNTHIA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.